CM4 — Genotoxicity, Carcinogenicity, Adverse Events, and Contraindications

go back

GENOTOXICITY
No evidence of cytotoxicity or mutagenic potential has been found in any test.

CARCINOGENICITY
No carcinogenicity studies were performed on CM4 as there was no mutagenic potential observed. It should be noted that CM4 has been used in the U.S. for more than 12 years and no carcinogenicity has been reported to date. No teratological effects have been reported or observed in any studies to date.

ADVERSE EVENTS
No major adverse events have been documented in the ongoing or completed trials with HIV/AIDS patients.

CONTRAINDICATIONS
None.